SCHEMBL4297245

SCHEMBL4297245

CCCCN1C(=O)NC(=O)CC1(N)N

nearest known ligand 0.35

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 5/20 0.35
KDM4E B2RXH2 1/20 0.34
LMNA P02545 1/20 0.34
CYP2C19 P33261 1/20 0.34
ALOX5 P09917 2/20 0.33
TSHR P16473 1/20 0.32
NPSR1 Q6W5P4 1/20 0.32
CRBN Q96SW2 1/20 0.32
MAPT P10636 1/20 0.32
ATM Q13315 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
GAA P10253 3/20 0.32
TP53 P04637 1/20 0.32
ABL1 P00519 2/20 0.30
RIN1 Q13671 2/20 0.30
TDP1 Q9NUW8 2/20 0.30
RGS4 P49798 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4285918 0.95 ALOX5 (0.38) CYP19A1KDM4ELMNACYP2C19ALOX5
SCHEMBL4284253 0.73 PTGS1 (0.37) KDM4ELMNACYP2C19MAPTTDP1
SCHEMBL5597442 0.70 CRBN (0.41) KDM4ELMNACYP2C19TSHRNPSR1
SCHEMBL194067 0.66 CRBN (0.46) KDM4ELMNAALOX5TSHRCRBN
SCHEMBL11383117 0.63 PTGS1 (0.46) KDM4ELMNACYP2C19ALOX5CRBN
SCHEMBL1364147 0.63 SMN1; SMN2 (0.40) MAPTATMSMN1; SMN2GAATP53
SCHEMBL2161839 0.63 MAPT (0.49) CYP19A1KDM4ELMNACYP2C19MAPT
Succinimide SCHEMBL7039031 0.62 CRBN (0.61) CYP19A1KDM4ELMNACYP2C19ALOX5
Succinimide SCHEMBL4639601 0.62 CRBN (0.61) CYP19A1KDM4ELMNACYP2C19ALOX5
Succinimide SCHEMBL27423831 0.62 CRBN (0.61) CYP19A1KDM4ELMNACYP2C19ALOX5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009157938-A1 A2B ADENOSINE RECEPTOR ANTAGONISTS FOR TREATING CANCER CV THERAPEUTICS, INC. (US) 2009-12-30 WO disclosed
EP-1444233-A2 A 2B? ADENOSINE RECEPTOR ANTAGONISTS CV THERAPEUTICS, INC. (US) 2004-08-11 EP disclosed
WO-2003042214-A2 A2B ADENOSINE RECEPTOR ANTAGONISTS CV THERAPEUTICS, INC. (US) 2003-05-22 WO disclosed